In agreement with some previous studies, our findings suggest that prostate cancer patients with low PSA concentrations may have some unique characteristics that result in low PSA concentrations having different effects on disease progression and prognosis with different T stages and GS. Here, KLK3 is linked to prostate carcinoma.